APP and Alzheimer disease: In vivo, reduced Reelin expression in AD mutant mice crossed with heterozygous reeler mice results in enhanced amyloidogenic APP processing and precocious production of Aβ peptides, a significant increase in number and size of Aβ plaques as well as age-related aggravation of plaque pathology in double mutant compared with single AD mutant [252].